This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Walter and Eliza Hall Institute of Medical Research. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- East Keilor, AU (2006 - 2009)
- Keilor East, AU (2009)
Company Filing History:
Years Active: 2006-2009
Title: Hamsa Puthalakath: Innovator in Therapeutic Molecules
Introduction
Hamsa Puthalakath is a prominent inventor based in East Keilor, Australia, known for his groundbreaking work in the field of therapeutic molecules. With a total of three patents to his name, Puthalakath focuses on innovations that modulate apoptosis in mammalian cells, contributing significantly to the medical research landscape.
Latest Patents
Puthalakath's latest patents showcase novel molecules capable of influencing apoptosis, a crucial process in cell life cycles. His primary inventions include:
1. **Therapeutic Molecules**: This invention pertains to new molecules that modulate apoptosis and encompasses genetic sequences encoding them. Particularly, it introduces a member of the Bcl-2 family of proteins named 'Bim'. These molecules have diverse applications, including therapy, diagnostics, and as tools for screening therapeutic agents that affect physiological cell death and entry into the cell cycle.
2. **Bcl-2-Modifying Factor (Bmf) Sequences**: This invention also focuses on molecules modulating apoptosis and encompasses a novel protein called 'Bmf', which interacts with pro-survival members of the Bcl-2 family. Bmf is classified as a BH3-only molecule, which is critical in triggering apoptosis. This invention even extends to genetically modified animals designed to help screen for agents that may alleviate symptoms related to apoptosis defects.
Career Highlights
Hamsa Puthalakath is currently associated with the Walter and Eliza Hall Institute of Medical Research, where he continues to innovate within the medical research community. His distinct contributions to the understanding of apoptosis have resonated throughout various scientific discussions and have opened pathways to potential treatments for diseases influenced by cell death mechanisms.
Collaborations
Throughout his career, Puthalakath has collaborated with esteemed colleagues such as Andreas Strasser and Lorraine Ann O'Reilly. These collaborations have not only strengthened his research but have also enhanced the impact of their collective findings in the field of apoptosis.
Conclusion
Hamsa Puthalakath exemplifies the spirit of innovation in medical research. His patents not only underline his dedication to advancing therapeutic approaches but also affirm his role as a key inventor in the fight against diseases related to apoptosis. Through ongoing research and collaboration, Puthalakath continues to contribute valuable insights that could shape future therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile